On May 8, 2025, Edwards Lifesciences Corp announced the approval of amendments to its Employee Stock Purchase Plans, increasing available shares by 4.2 million for U.S. employees and 1.46 million for international employees at its Annual Meeting. Additionally, all director nominees were elected, and executive compensation was approved.